No Data
No Data
Earnings Preview: BMRN to Report Financial Results Post-market on October 29
$Biomarin Pharmaceutical(BMRN.US)$ is scheduled to release its financial results post-market on October 29 ET. Earnings PreviewAnalysts estimate $Biomarin Pharmaceutical(BMRN.US)$ to post revenue of
Piper Sandler Maintains Biomarin Pharmaceutical(BMRN.US) With Buy Rating, Maintains Target Price $122
Here's Why BioMarin Pharmaceutical (BMRN) Is a Strong Growth Stock
Possible Bearish Signals With BioMarin Pharmaceutical Insiders Disposing Stock
BioMarin to Host Third Quarter 2024 Financial Results Conference Call and Webcast on Tuesday, October 29, 2024, at 4:30pm ET
How Is The Market Feeling About Biomarin Pharmaceutical?